-$14M
Net insider buying / selling at Corteva Agriscience (CTVA) over the last 2 years. Updated Feb 24, 2026

Are Corteva Agriscience Insiders Buying or Selling?

Corteva Agriscience (CTVA) has had no reported insider transactions in the past 90 days. The most recent was BRIAN TITUS, who sold 4,311 shares at $76.57 on February 20, 2026.

Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the CTVA AI Score. For government officials trading this stock, see CTVA congressional trading.

Who’s Trading Corteva Agriscience Stock?

InsiderActivityTradesLast Trade
CORNEL FUERER Sold $6.1M 2 May 13, 2025
Charles Magro Sold $3M 1 Feb 19, 2025
Robert King Sold $2.8M 1 Aug 29, 2025
BRIAN TITUS Sold $2.3M 3 Feb 20, 2026

Recent Corteva Agriscience Insider Transactions

Insider Transaction Date Type Shares Price Value
BRIAN TITUSFeb 20, 2026Sell4,311$76.57$330,000
BRIAN TITUSFeb 20, 2026Sell4,000$76.53$310,000
Robert KingAug 29, 2025Sell37,280$74.2$2.8M
CORNEL FUERERMay 13, 2025Sell55,242$68.06$3.8M
BRIAN TITUSFeb 20, 2025Sell26,560$63.74$1.7M
Charles MagroFeb 19, 2025Sell46,905$63.82$3M
CORNEL FUERERNov 26, 2024Sell37,672$63.4$2.4M

Frequently Asked Questions: Corteva Agriscience Insider Trading

Corteva Agriscience insiders have not reported any transactions in the past 90 days.

The most recent sale was by BRIAN TITUS who sold 4,311 shares on February 20, 2026. View all transactions in the table on this page.

Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.

FUERER CORNEL B has sold the most CTVA stock in the last 2 years, with a total value of $6.1M.

The total value of insider transactions for Corteva Agriscience in the last 2 years is negative, amounting to -$14M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.